The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation (Q34297130)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation |
scientific article |
Statements
1 reference
The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation (English)
1 reference
Hermann Haller
1 reference
Jan Menne
1 reference
Eberhard Ritz
1 reference
Christos Chatzikyrkou
1 reference
Giancarlo Viberti
1 reference
1 January 2014
1 reference
1 reference
Identifiers
1 reference